Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.93% |
| 2 | Technology | 4.66% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 4.14% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRNT
4901
DELISTED
Verint Systems
VRNT
| $1.33M | ﹤0.01% |
52,198
-251,810
| -83% | -$6.12M |
|
4902
CALL
MiMedx Group
MDXG
$622M
| $1.33M | ﹤0.01% |
215,300
-66,300
| -24% | -$300K |
|
4903
PUT
Avnet
AVT
$7.86B
| $1.33M | ﹤0.01% |
29,700
+23,400
| +371% | +$1.07M |
|
|
BBBY
4904
Bed Bath & Beyond
BBBY
$415M
| $1.33M | ﹤0.01% |
63,911
-17,971
| -22% | -$443K |
|
4905
CALL
MKS Inc
MKSI
$21B
| $1.33M | ﹤0.01% |
16,600
-5,200
| -24% | -$475K |
|
4906
PUT
Texas Roadhouse
TXRH
$13.6B
| $1.33M | ﹤0.01% |
19,200
+2,500
| +15% | +$170K |
|
4907
DMC Global
BOOM
$155M
| $1.33M | ﹤0.01% |
32,563
+5,669
| +21% | +$242K |
|
4908
CALL
Hyatt Hotels
H
$17.1B
| $1.33M | ﹤0.01% |
16,700
+6,700
| +67% | +$526K |
|
4909
CALL
Western Alliance Bancorporation
WAL
$8.98B
| $1.33M | ﹤0.01% |
23,300
+10,600
| +83% | +$611K |
|
4910
Westwood Holdings Group
WHG
$186M
| $1.33M | ﹤0.01% |
25,641
+18,054
| +238% | +$1.03M |
|
4911
CALL
Everest Group
EG
$14.2B
| $1.32M | ﹤0.01% |
5,800
-700
| -11% | -$157K |
|
4912
WPP
WPP
$5.8B
| $1.32M | ﹤0.01% |
18,087
-29,651
| -62% | -$2.31M |
|
4913
PUT
FIVE9
FIVN
$2.47B
| $1.32M | ﹤0.01% |
30,300
+16,700
| +123% | +$689K |
|
4914
Winnebago Industries
WGO
$892M
| $1.32M | ﹤0.01% |
39,903
+4,373
| +12% | +$169K |
|
|
AGEN
4915
Agenus
AGEN
$329M
| $1.32M | ﹤0.01% |
31,494
-8,442
| -21% | -$332K |
|
4916
PUT
Verastem
VSTM
$596M
| $1.32M | ﹤0.01% |
15,183
+2,400
| +19% | +$239K |
|
4917
PUT
Keysight
KEYS
$61.1B
| $1.32M | ﹤0.01% |
19,900
+7,900
| +66% | +$490K |
|
4918
Reliance Steel & Aluminium
RS
$21.8B
| $1.32M | ﹤0.01% |
15,467
-54,438
| -78% | -$4.82M |
|
|
MFGP
4919
CALL
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $1.32M | ﹤0.01% |
58,926
+1,488
| +3% | +$30.2K |
|
|
BKS
4920
PUT
DELISTED
Barnes & Noble
BKS
| $1.31M | ﹤0.01% |
226,700
+74,600
| +49% | +$421K |
|
4921
Editas Medicine
EDIT
$433M
| $1.31M | ﹤0.01% |
41,272
-46,824
| -53% | -$1.51M |
|
|
PTLA
4922
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.31M | ﹤0.01% |
49,200
+4,500
| +10% | +$147K |
|
|
AXDX
4923
PUT
DELISTED
Accelerate Diagnostics
AXDX
| $1.31M | ﹤0.01% |
5,700
-1,180
| -17% | -$261K |
|
4924
CALL
National Health Investors
NHI
$3.58B
| $1.31M | ﹤0.01% |
17,300
+5,700
| +49% | +$435K |
|
4925
iShares Core Universal USD Bond ETF
IUSB
$43.2B
| $1.31M | ﹤0.01% |
+26,596
| New | +$1.31M |
|
Similar funds
Ken Griffin's Q3 2018 Portfolio in Review
As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Ken Griffin opened 1,427 new positions and closed 1,043 in Q3 2018.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.